Xynomic Pharmaceuticals IPO


Xynomic Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing oncology drug candidates.

Total Funding to Date$21.8MM
Register for Details

For more details on financing and valuation for Xynomic Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in